Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator
1 other identifier
interventional
40
1 country
1
Brief Summary
This study is looking at how safe and effective G-POEM, GES and a combination of both are for people with severe stomach problems (gastroparesis) that haven't gotten better with medicine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 19, 2025
CompletedFirst Submitted
Initial submission to the registry
April 8, 2026
CompletedFirst Posted
Study publicly available on registry
April 14, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2028
April 30, 2026
April 1, 2026
3.8 years
April 8, 2026
April 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Gastroparesis Symptom Changes
Monitoring changes in gastroparesis symptom severity as measured by the Gastroparesis Cardinal Symptom Index (GCSI). A 9-item patient reported questionnaire with a rating scale of 0-5 ranging from 0 (none) to 5 (very severe).
Baseline, Preoperative 3 months, 6 months, 9 months, 12 months
Secondary Outcomes (8)
Subjects quality of life
Baseline, 6 months, 12 months.
Weight
Baseline, 6 months, 12 months
BMI
Baseline, 6 months, 12 months
Nutritional Support Status
Baseline, 6 months, 12 months
Gastroparesis-related hospitalizations
12 month follow-up
- +3 more secondary outcomes
Study Arms (4)
Control group
ACTIVE COMPARATORGES off + Upper Endoscopy
GES only
ACTIVE COMPARATORGES on + Upper Endoscopy
G-POEM only
ACTIVE COMPARATORGES off + GPOEM
Combination G-POEM and GES
ACTIVE COMPARATORGES on + GPOEM
Interventions
Participants will receive implantation of a gastric electrical stimulator (GES) with upper endoscopy (which is routine during GES placement), without undergoing G-POEM. The stimulator will remain off for the first 6 months and will then be turned on for the following 6 months.
Participants will receive implantation of a gastric electrical stimulator (GES) with upper endoscopy (which is routine during GES placement), without undergoing G-POEM. The stimulator will stay on for the first 6 months and will then be turned off for the following 6 months.
Participants will receive implantation of a gastric electrical stimulator (GES) with upper endoscopy (which is routine during GES placement) and G-POEM surgery. The stimulator will remain off for the first 6 months and will then be turned on for the following 6 months.
Participants will receive implantation of a gastric electrical stimulator (GES) with upper endoscopy (which is routine during GES placement) and G-POEM. POEM. The stimulator will stay on for the first 6 months and will then be turned on for the following 6 months.
Eligibility Criteria
You may qualify if:
- Adult patients of age 18 years and older
- Patients must be able to consent
- Documented diagnosis of refractory GP as determined by the following criteria:
- Medically refractory GP symptoms for \> 1 year despite treatment with first-line modalities and pharmacotherapies with anti-emetics and prokinetics AND
- Gastric emptying scintigraphy showing delayed gastric emptying with retention of \>60% at 2h and/or greater than 10% at 4h based on standardized radionuclide solid meal test
- Preoperative Gastroparesis Cardinal Symptom Index (GCSI) Score
- A decision to treat patient with surgical therapy of G-POEM and/or electric stimulator
You may not qualify if:
- Patients with prior surgical intervention for gastroparesis
- Patients less than 18 years old
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baylor University Medical Center
Dallas, Texas, 75246, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marc Ward, MD
Baylor Health Care System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 8, 2026
First Posted
April 14, 2026
Study Start
March 19, 2025
Primary Completion (Estimated)
December 30, 2028
Study Completion (Estimated)
December 30, 2028
Last Updated
April 30, 2026
Record last verified: 2026-04